Get started
Author

Ziya Kalkan

Observed names: Kalkan, Ziya, Z. Kalkan, Ziya KALKAN, ziya kalkan
Institution: Dicle University
ORCID: 0000-0001-7858-8180
Observed ORCID: 0000-0001-7858-8180
OpenAlex ID: A5015745342
Efficacy and Safety Profile of COVID-19 Vaccine in Cancer Patients: A Prospective, Multicenter Cohort Study
2022 · Ayse Irem Yasin, Sabin Göktas Aydin, et al. · Future Oncology · 30
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
2023 · Cengiz Karacin, Berna Oksuzoglu, et al. · BMC Cancer · 24
PDF
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group
2023 · Çağlar Ünal, Abdulmunir Azizy, et al. · The Oncologist · 11
PDF
Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes
2024 · Mehmet Fatih Ozbay, Hakan Harputluoglu, et al. · Cancers · 10
18F-FDG PET/CT parameters for prediction of response to neoadjuvant therapy and prognosis in rectal cancer
2022 · Senar Ebinç, Yunus Güzel, et al. · Nuclear Medicine Communications · 10
Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study
2025 · Ziya Kalkan, Senar Ebinc, et al. · Medicina · 6
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
2023 · Cengiz Karacin, Berna Oksuzoglu, et al. · BMC Cancer · 5
PDF
Predictive and prognostic effect of ABO blood group on immune checkpoint inhibitors
2022 · Yakup Ergun, Selin Akturk Esen, et al. · Cancer Biomarkers · 5
PDF
Factors Influencing HER2 Discordance in Nonmetastatic Breast Cancer and The Role of Neoadjuvant Therapy
2022 · Senar Ebinç, Zeynep Oruç, et al. · Future Oncology · 4
Successful Dialysis Treatment of Metformin Associated Lactic Acidosis, Report of Two Cases.
2020 · Emrah Günay, Ziya Kalkan, et al. · Iranian Journal of Kidney Diseases · 4
PDF
Prognostic factors and the prognostic role of inflammation indices in malignant pleural mesothelioma
2023 · Senar Ebinç, Zeynep Oruç, et al. · Turkish Journal of Thoracic and Cardiovascular Surgery · 3
PDF
Comparison of the Efficacy and Safety of 3 Months of CAPOX Followed by 3 Months of Capecitabine and 6 Months of CAPOX/FOLFOX in the Adjuvant Treatment of Low-Risk Stage III Colon Cancer Treated Surgically
2023 · Murat Bardakci, Derya Demirtas Esmer, et al. · Oncology · 3
Evaluation of Factors Predicting the Effectiveness of Regorafenib in the Treatment of Metastatic Colorectal Cancer
2022 · Senar Ebinç, Zeynep Oruç, et al. · Eurasian Journal of Medicine · 3
Causes of liver test abnormalities in newly diagnosed cancer patients and the investigation of etiological factors
2024 · Zuhat Urakçı, Senar Ebinç, et al. · Postgraduate Medicine · 2
COVİD-19 ve Kanser Yönetimi
2021 · Zuhat URAKÇI, Ziya KALKAN, et al. · Dicle Medical Journal / Dicle Tip Dergisi · 2
PDF
Comparative Safety Profiles of Sacituzumab Govitecan and Datopotamab Deruxtecan: A Real-World Pharmacovigilance Study
2026 · Ziya Kalkan, Murat Bardakci, et al. · Journal of Clinical Medicine · 1
Evaluation of treatment regimens and prognostic factors in primary central nervous system lymphomas
2025 · Nadiye Akdeniz, Senar Ebinç, et al. · Journal of Current Hematology & Oncology Research · 1
Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study
2025 · Neslihan Özyurt, Ali Alkan, et al. · Scientific Reports · 1
Comparison of inflammatory indices in patients with metastatic non-small cell lung cancer
2025 · Zuhat Urakçı, Zeynep Oruc, et al. · Revista da Associação Médica Brasileira · 1
PDF
The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study
2024 · Neslihan Özyurt, Ali Alkan, et al. · Scientific Reports · 1
Immunotherapy in Solid Tumors
2024 · Ziya Kalkan, Zeynep Oruc · 1
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
2023 · Caglar Unal, Nalan Alan Selcuk, et al. · Eurasian Journal of Medicine and Oncology · 1
PDF
Factors influencing the prognosis in Braf wild-type metastatic malignant melanoma and the role of novel inflammation indices
2023 · Senar Ebinç, Ziya Kalkan, et al. · TURKDERM · 1
PDF
Comparison of Two Chemotherapy Regimens After First-Line Treatment for HER2-Negative Metastatic Gastric Cancer
2023 · Zuhat Urakçı, Senar Ebinç, et al. · Cureus · 1
PDF
Neoadjuvant Therapy and Factors Influencing Survival in Locally Advanced Non-Small Cell Lung Cancer
2023 · Senar Ebinç, Zeynep Oruç, et al. · Cureus · 1
PDF
Works count: 43
Citation count: 135
H-index: 6
I10-index: 5
Year
Topic
Type